$GILD (Gilead Sciences) Support & Resistance Levels, AI Price Target & Institutional Flow.
Today, $GILD (Gilead Sciences) trades at $166.43 (-0.06%) with a 62/100 Momentum Pulse (CONSOLIDATION) and 14D RSI at 43.8 (PULLBACK ZONE (43.8)). Unlock the live $GILD support and resistance levels, 30D Put Wall floor, 20D SMA pivot, Call Wall ceiling, dark pool flow, and locked 1-Month AI Price Target (+14.2% upside corridor) below—or create a free 24/7 AI quant agent to guard $GILD.
Spot Price: $166.43 | 30-Day Support Floor: $147.92 (11.12% above) | 10-Day EMA: $168.21 | 20-Day SMA Pivot: $167.29 | 30-Day Resistance Ceiling: $174.48 (4.84% below) | 14-Day RSI: 43.8 (PULLBACK ZONE (43.8)) | 30-Day Trading Corridor: 17.96% span. Value and mean-reversion buyers in Gilead Sciences ($GILD) are monitoring the $147.92 30-day mechanical support floor (spot price at $166.43 sits 11.12% above support with 14-day RSI at 43.8 (PULLBACK ZONE (43.8))). Reclaiming the 10-day EMA ($168.21) and 20-day SMA pivot ($167.29) is the primary technical trigger to ignite a move back toward the $174.48 resistance ceiling.
$GILD (Gilead Sciences) Live Key Levels, RSI & Valuation Matrix
| $GILD Technical Metric | Live Value | $GILD Fundamental / Regime Metric | Live Status |
|---|---|---|---|
| Live Spot Price (24h Change) | $166.43 (-0.06%) | Market Capitalization | Tracked in Terminal |
| 30-Day Mechanical Support Floor (Put Wall) | $147.92 (11.12% cushion) | 52-Week High / Low Range | $116.88 – $176.58 |
| 20-Day Simple Moving Average (20D SMA) | $167.29 | Trailing P/E Ratio & Dividend Yield | Growth / N/A • Yield: 1.95% |
| 10-Day Exponential Moving Average (10D EMA) | $168.21 | Average Daily Volume (Liquidity) | 6.75M shares |
| 30-Day Resistance Ceiling (Call Wall) | $174.48 (4.84% upside to test) | Next Scheduled Earnings / Catalyst Window | 2026-10-29 |
| 14-Day Relative Strength Index (RSI) | PULLBACK ZONE (43.8) | Saku Momentum Pulse & Health Rating | 62/100 Momentum • 64/100 Health |
Should You Buy $GILD Stock Now or Wait?
Value and mean-reversion buyers in Gilead Sciences ($GILD) are monitoring the $147.92 30-day mechanical support floor (spot price at $166.43 sits 11.12% above support with 14-day RSI at 43.8 (PULLBACK ZONE (43.8))). Reclaiming the 10-day EMA ($168.21) and 20-day SMA pivot ($167.29) is the primary technical trigger to ignite a move back toward the $174.48 resistance ceiling.
$GILD (Gilead Sciences) is currently trading below its 20-day simple moving average ($167.29) after a +10.64% 30-day move. If buyers fail to defend the 30-day mechanical support floor at $147.92 (11.12% above current spot), negative dealer gamma hedging can accelerate downside discovery toward the lower end of its 52-week range ($116.88).
$GILD Support & Resistance, Institutional Flow & Catalysts.
$GILD Support & Resistance
Spot Price: $166.43 | 30-Day Support Floor: $147.92 (11.12% above) | 10-Day EMA: $168.21 | 20-Day SMA Pivot: $167.29 | 30-Day Resistance Ceiling: $174.48 (4.84% below) | 14-Day RSI: 43.8 (PULLBACK ZONE (43.8)) | 30-Day Trading Corridor: 17.96% span.
$GILD Institutional & Whale Flow
Institutional order flow for $GILD (averaging 6.75M shares daily volume) is concentrated between the $147.92 Put Wall support zone and $174.48 Call Wall resistance ceiling, with a live Saku Fundamental Health score of 64/100.
$GILD Catalyst Outlook
Next scheduled earnings window for Gilead Sciences ($GILD): 2026-10-29. Latest tracked headline from finance.yahoo.com: "Lakefront Biotherapeutics Eyes 2027 Trials for Autoimmune Drug, Backed by €2.2 Billion in Cash".
Latest $GILD (Gilead Sciences) Breaking News & Headlines
About Gilead Sciences ($GILD)
Gilead Sciences ($GILD) is an actively traded institutional asset tracked inside the Saku AI Terminal.
Saku's quantitative engine continuously monitors $GILD's 30-day mechanical support floor ($147.92), 20-day simple moving average ($167.29), and 30-day resistance ceiling ($174.48) alongside off-exchange dark pool block prints and SEC filings.
Hatch Your Own 24/7 AI Co-Pilot to Guard $GILD.
Step inside the 3D Quant Sanctuary and claim Workstation #4 to hatch your personal AI analyst (Momentum, Dip-Buyer, or Value & Catalyst style). Your agent monitors $GILD 24/7 with locked 1-month price targets, hard stop-loss tripwires, 3x/day shift briefings, and live Koi Bridge debates.

What are the live 30-day support and resistance levels for $GILD (Gilead Sciences)?
Spot Price: $166.43 | 30-Day Support Floor: $147.92 (11.12% above) | 10-Day EMA: $168.21 | 20-Day SMA Pivot: $167.29 | 30-Day Resistance Ceiling: $174.48 (4.84% below) | 14-Day RSI: 43.8 (PULLBACK ZONE (43.8)) | 30-Day Trading Corridor: 17.96% span. $GILD currently registers a Saku Momentum Pulse score of 62/100 and a Fundamental Health score of 64/100.
Why is $GILD (Gilead Sciences) moving and what is the bull vs. bear thesis?
Bull Thesis: Value and mean-reversion buyers in Gilead Sciences ($GILD) are monitoring the $147.92 30-day mechanical support floor (spot price at $166.43 sits 11.12% above support with 14-day RSI at 43.8 (PULLBACK ZONE (43.8))). Reclaiming the 10-day EMA ($168.21) and 20-day SMA pivot ($167.29) is the primary technical trigger to ignite a move back toward the $174.48 resistance ceiling. Bear Thesis: $GILD (Gilead Sciences) is currently trading below its 20-day simple moving average ($167.29) after a +10.64% 30-day move. If buyers fail to defend the 30-day mechanical support floor at $147.92 (11.12% above current spot), negative dealer gamma hedging can accelerate downside discovery toward the lower end of its 52-week range ($116.88).
What are $GILD's key fundamentals, 52-week range, and upcoming catalysts?
Gilead Sciences ($GILD) trades with a market cap of tracked institutional scale, and a 52-week range of $116.88 to $176.58. Next scheduled earnings window for Gilead Sciences ($GILD): 2026-10-29. Latest tracked headline from finance.yahoo.com: "Lakefront Biotherapeutics Eyes 2027 Trials for Autoimmune Drug, Backed by €2.2 Billion in Cash".